Viewing Study NCT02437604


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-04-04 @ 3:42 AM
Study NCT ID: NCT02437604
Status: COMPLETED
Last Update Posted: 2021-11-09
First Post: 2015-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: FSS-AS-10042
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators